Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784544 · ClinicalTrials.gov registry record · NA
The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity
A NA study, sponsored by United States Army Research Institute of Environmental Medicine.
- Not yet
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT06784544: Clinical Trial NA study, sponsored by United States Army Research Institute of Environmental Medicine.
NCT06784544 is a NA study that has not yet begun recruiting, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784544, a NA study, has not yet begun recruiting, sponsored by United States Army Research Institute of Environmental Medicine.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This longitudinal study will examine the effects of repeated bouts of operational stress and limited recovery on integrated MPS, whole-body protein balance, iron absorption, and aerobic performance. Following baseline characterization measures, active adults (n=24) representative of normal weight phenotype (NW; n=12) and overweight phenotype (OW; n=12) will complete a 48h balance phase preceding two rounds of repeated 72h energy deficit exposure each immediately followed by a 48h recovery phase. NW cutoff will be defined ≤ 22% body fat for males and ≤ 32% body fat for females. OW cutoff will be defined as \>22% body fat for males and \>32% body fat for females. These body composition cutoffs are informed by the maximum allowable percent body fat standards outlined in current Army Regulation 600-9. Additional details for determining % body fat are outlined in the experimental procedures section of the protocol.
Primary Outcome
deuterium oxide stable isotope
Interventions
- OTHER Operational Stressors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-05 |
| Est. Completion | 2025-11 |
| Phase | NA |
What is known before NCT06784544 opens enrollment
NCT06784544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Operational Stressors is the first listed.
NCT06784544 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06784544 about?
NCT06784544 is a clinical study titled "The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity". This longitudinal study will examine the effects of repeated bouts of operational stress and limited recovery on integrated MPS, whole-body protein balance, iron absorption, and aerobic performance. Following baseline characterization measures, active adults (n=24) representative of normal weight ph...
What is the current status of trial NCT06784544?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-05. Estimated completion is 2025-11.
What interventions are being tested in trial NCT06784544?
The interventions under investigation include: Operational Stressors (OTHER).
Who is sponsoring clinical trial NCT06784544?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06784544's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia